264 related articles for article (PubMed ID: 23750285)
21. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.
Xin XM; Zhong MX; Yang GL; Peng Y; Zhang YL; Zhu W
World J Gastroenterol; 2014 Nov; 20(42):15727-35. PubMed ID: 25400456
[TBL] [Abstract][Full Text] [Related]
22. Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen.
Bougaret L; Delort L; Billard H; Le Huede C; Boby C; De la Foye A; Rossary A; Mojallal A; Damour O; Auxenfans C; Vasson MP; Caldefie-Chezet F
PLoS One; 2018; 13(2):e0191571. PubMed ID: 29389973
[TBL] [Abstract][Full Text] [Related]
23. Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells.
Takahata C; Miyoshi Y; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Cancer Lett; 2007 Jun; 250(2):229-36. PubMed ID: 17123704
[TBL] [Abstract][Full Text] [Related]
24. Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario.
Cancel M; Pouillot W; Mahéo K; Fontaine A; Crottès D; Fromont G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142673
[TBL] [Abstract][Full Text] [Related]
25. Adipokines as therapeutic targets in breast cancer treatment.
Cha YJ; Koo JS
Expert Opin Ther Targets; 2018 Nov; 22(11):941-953. PubMed ID: 30332900
[TBL] [Abstract][Full Text] [Related]
26. The Tumor Promotional Role of Adipocytes in the Breast Cancer Microenvironment and Macroenvironment.
Bernard JJ; Wellberg EA
Am J Pathol; 2021 Aug; 191(8):1342-1352. PubMed ID: 33639102
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
28. Signals from the Adipose Microenvironment and the Obesity-Cancer Link-A Systematic Review.
Himbert C; Delphan M; Scherer D; Bowers LW; Hursting S; Ulrich CM
Cancer Prev Res (Phila); 2017 Sep; 10(9):494-506. PubMed ID: 28864539
[TBL] [Abstract][Full Text] [Related]
29. Tumor Metabolic Reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression.
Pham DV; Park PH
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535537
[TBL] [Abstract][Full Text] [Related]
30. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.
He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L
Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531
[TBL] [Abstract][Full Text] [Related]
31. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
[TBL] [Abstract][Full Text] [Related]
32. Modulation of inter-organ signalling in obese mice by spontaneous physical activity during mammary cancer development.
Le Guennec D; Hatte V; Farges MC; Rougé S; Goepp M; Caldefie-Chezet F; Vasson MP; Rossary A
Sci Rep; 2020 May; 10(1):8794. PubMed ID: 32472095
[TBL] [Abstract][Full Text] [Related]
33. Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis.
Kawashima K; Maeda K; Saigo C; Kito Y; Yoshida K; Takeuchi T
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422056
[TBL] [Abstract][Full Text] [Related]
34. The pleiotropic roles of adipocyte secretome in remodeling breast cancer.
Zhou X; Zhang J; Lv W; Zhao C; Xia Y; Wu Y; Zhang Q
J Exp Clin Cancer Res; 2022 Jun; 41(1):203. PubMed ID: 35701840
[TBL] [Abstract][Full Text] [Related]
35. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
36. Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation.
Zhang H; Wang M; Xu Y
Cancer Biol Med; 2023 Mar; 20(4):268-86. PubMed ID: 36880535
[TBL] [Abstract][Full Text] [Related]
37. Adipocyte regulation of cancer stem cells.
Khaledian B; Thibes L; Shimono Y
Cancer Sci; 2023 Nov; 114(11):4134-4144. PubMed ID: 37622414
[TBL] [Abstract][Full Text] [Related]
38. Peritumoral expression of adipokines and fatty acids in breast cancer.
Gnerlich JL; Yao KA; Fitchev PS; Goldschmidt RA; Bond MC; Cornwell M; Crawford SE
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S731-8. PubMed ID: 24052317
[TBL] [Abstract][Full Text] [Related]
39. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
40. Expression of AdipoR1 and AdipoR2 Receptors as Leptin-Breast Cancer Regulation Mechanisms.
Mociño-Rodríguez MD; Santillán-Benítez JG; Dozal-Domínguez DS; Hernández-Navarro MD; Flores-Merino MV; Sandoval-Cabrera A; García Vázquez FJ
Dis Markers; 2017; 2017():4862016. PubMed ID: 29311755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
